Evaluation of Adult Patients with Fatigue and Suspected Hypothyroidism
Begin with serum TSH as the single initial screening test; if TSH is elevated (>4-5 mIU/L), then measure free T4 to distinguish overt from subclinical hypothyroidism, and treat with levothyroxine when TSH exceeds 10 mIU/L. 1
1. Pathophysiology Connecting Thyroid Dysfunction to Fatigue
Thyroid hormones (T4 and T3) regulate cellular metabolism throughout the body. When thyroid hormone production decreases, multiple metabolic processes slow down:
- Decreased basal metabolic rate leads to reduced energy production at the cellular level, manifesting as profound fatigue 1
- Slowed cardiac function reduces resting heart rate and cardiac output, contributing to exercise intolerance 1
- Altered neurotransmitter metabolism affects mood, cognition, and energy perception
- Muscle metabolism changes cause elevated creatine kinase (MM fraction) and muscle weakness 1
The most common cause is autoimmune thyroiditis (Hashimoto's disease), where thyroid peroxidase antibodies (TPOAb) progressively destroy thyroid tissue 1. This autoimmune process explains why hypothyroidism frequently coexists with other autoimmune conditions.
2. History, Physical Examination, and Differential Diagnosis
Critical History Questions
Ask specifically about:
- Duration and pattern of fatigue: Chronic (>6 weeks) vs. acute 2
- Cold intolerance (not just feeling cold, but intolerance compared to others)
- Weight gain despite unchanged diet
- Constipation (new or worsening)
- Dry skin and hair changes (coarsening, hair loss)
- Voice changes (hoarseness, deepening) 1
- Menstrual irregularities (menometrorrhagia) 1
- Muscle cramps and weakness 1
- Cognitive changes (memory problems, difficulty concentrating)
- Sleep disturbances including new-onset sleep apnea 1
High-Risk Features Requiring TSH Testing
Compelling evidence supports case-finding (not universal screening) in patients with: 1
- Autoimmune diseases (type 1 diabetes, pernicious anemia, celiac disease, rheumatoid arthritis)
- First-degree relative with autoimmune thyroid disease
- History of neck radiation or radioactive iodine therapy
- Prior thyroid surgery or dysfunction
- Medications: lithium, amiodarone, interferon-alpha, tyrosine kinase inhibitors 1
- Psychiatric disorders
- Down syndrome or Turner syndrome 1
Physical Examination Findings
Look for:
- Thyroid gland: Palpable goiter or nodules
- Skin: Dry, cool, pale, non-pitting edema (myxedema)
- Hair: Coarse, brittle; loss of lateral eyebrows
- Cardiovascular: Bradycardia, distant heart sounds
- Neurologic: Delayed ankle reflex relaxation time (though rarely used clinically) 1
- Carpal tunnel signs in severe cases 1
Differential Diagnoses for Fatigue
The vast majority of fatigued patients do NOT have hypothyroidism 3. Consider:
Physical causes:
- Anemia (iron deficiency, B12 deficiency, chronic disease)
- Diabetes mellitus
- Chronic kidney disease
- Liver disease
- Chronic infections (HIV, hepatitis, tuberculosis)
- Malignancy
- Sleep disorders (obstructive sleep apnea, insomnia)
- Medication side effects
Psychological causes:
- Depression (screen with specific questions about mood, anhedonia) 4
- Anxiety disorders 4
- Chronic fatigue syndrome/ME/CFS (requires post-exertional malaise) 4
Lifestyle factors:
- Poor sleep hygiene
- Excessive alcohol use
- Sedentary lifestyle
- Nutritional deficiencies
3. Initial Laboratory Testing and Interpretation
Recommended Initial Tests
For fatigue evaluation, order: 4
- Serum TSH (primary screening test)
- Complete blood count (CBC)
- Comprehensive metabolic panel (glucose, electrolytes, kidney function)
- Liver enzymes (ALT, AST, γ-GT)
- C-reactive protein (CRP) or ESR
Important caveat: While these tests are commonly ordered, abnormal results leading to significant diagnoses are uncommon in primary care fatigue presentations 5. The pick-up rate for serious disease is low 5.
TSH Interpretation Algorithm
TSH is the single best screening test for primary hypothyroidism because the pituitary is exquisitely sensitive to thyroid hormone levels 1.
Interpretation framework:
TSH <0.1 mIU/L: Suggests hyperthyroidism or over-treatment; measure free T4 and refer
TSH 0.1-4.5 mIU/L: Normal range; hypothyroidism is excluded in outpatients 1
TSH 4.5-10 mIU/L:
- Measure free T4
- If free T4 is low → overt hypothyroidism → treat
- If free T4 is normal → subclinical hypothyroidism → consider treatment based on symptoms, TPOAb status, and patient factors 1
TSH >10 mIU/L:
- Measure free T4
- Treatment is generally indicated regardless of free T4 level 1
Free T4 Interpretation
- Low free T4 + elevated TSH = Overt primary hypothyroidism → Treat
- Normal free T4 + elevated TSH = Subclinical hypothyroidism → Selective treatment
- Low free T4 + normal or low TSH = Central hypothyroidism (pituitary/hypothalamic) → Refer to endocrinology 1
Critical Pitfalls in TSH Interpretation
TSH can be falsely elevated or misleading in: 1
- Acute illness/hospitalization: Avoid testing unless strong clinical suspicion; TSH may be suppressed or elevated during recovery phase 1
- Untreated adrenal insufficiency: TSH normalizes after glucocorticoid replacement; always treat suspected Addison's disease before diagnosing hypothyroidism 1
- Pregnancy first trimester: TSH normally decreases due to hCG stimulation 1
- Medications: Dopamine, high-dose glucocorticoids suppress TSH 1
- Heterophilic antibodies: Rare cause of falsely elevated TSH 1
Do not routinely order T3 levels in primary hypothyroidism evaluation; they add no diagnostic value 1.
4. How Laboratory Results Influence Treatment Decisions
Clear Treatment Indications
Treat with levothyroxine when: 1
- TSH >10 mIU/L (regardless of symptoms or free T4 level)
- TSH 4.5-10 mIU/L + low free T4 (overt hypothyroidism)
- TSH 4.5-10 mIU/L + normal free T4 (subclinical) IF:
- Patient has clear hypothyroid symptoms
- Positive TPOAb (indicates autoimmune etiology with progression risk)
- Pregnancy or planning pregnancy
- Goiter present
- Elevated LDL cholesterol refractory to other interventions
When NOT to Treat
Do not treat if: 1
- TSH 4.5-10 mIU/L with normal free T4 in asymptomatic patients without risk factors
- TSH elevation during acute illness (recheck after recovery)
- TSH elevation in setting of untreated adrenal insufficiency (treat adrenal first)
Important: There is no evidence supporting treatment of "subclinical hypothyroidism" with normal TSH values, despite patient beliefs about "low thyroid" 3. Normal thyroid function tests exclude hypothyroidism as a cause of fatigue.
Additional Testing to Consider
Measure TPOAb when: 1
- Confirming autoimmune etiology in documented hypothyroidism
- Assessing progression risk in subclinical hypothyroidism
- Patient has other autoimmune diseases
Do NOT routinely measure:
- Thyroglobulin antibodies (less useful than TPOAb)
- Reverse T3 (no clinical utility)
- Thyroid ultrasound (unless palpable nodule or goiter)
5. First-Line Medication Management, Monitoring, and Follow-Up
Levothyroxine (L-T4) Dosing
Starting dose depends on patient age and cardiac status:
Healthy adults <60 years without cardiac disease: Start full replacement dose of 1.6-1.8 mcg/kg/day 1
- Example: 70 kg patient = 100-125 mcg daily
Elderly patients (>60 years) OR cardiac disease: Start low at 25-50 mcg daily and titrate slowly every 4-6 weeks 1
Dosing principles:
- Take on empty stomach, 30-60 minutes before breakfast
- Avoid simultaneous administration with calcium, iron, proton pump inhibitors (separate by 4 hours)
- Use brand-name or consistent generic formulation (bioavailability varies)
Treatment Goal
Target TSH: 0.5-2.5 mIU/L for most patients 1
Restoration to euthyroid state should normalize:
- Resting heart rate
- Serum cholesterol
- Sleep patterns
- Menstrual cycles
- Elevated creatine kinase or liver enzymes 1
Monitoring Schedule
- Recheck TSH and free T4 in 6-8 weeks after starting treatment or dose change 1
- Adjust dose in 12.5-25 mcg increments based on TSH
- Once stable: Check TSH annually
- Recheck sooner if:
- Significant weight change (>10%)
- Pregnancy
- New medications that affect absorption or metabolism
- Symptoms of over- or under-treatment
Signs of Over-Treatment (Iatrogenic Hyperthyroidism)
- TSH <0.1 mIU/L
- Palpitations, tremor, anxiety
- Weight loss
- Insomnia
- Increased risk of atrial fibrillation and osteoporosis with chronic suppression
What NOT to Do
Do NOT use combination T4/T3 therapy in primary hypothyroidism; no evidence of benefit over T4 alone 3. T3 has no role in routine management 3.
6. Important Differences in Management for Older Adults
Age-Specific Considerations
Older adults (>60-65 years) require modified approach: 1
Lower starting doses: Begin at 25-50 mcg daily (not full replacement)
- Rationale: Higher risk of undiagnosed coronary artery disease; rapid thyroid hormone replacement can precipitate angina or myocardial infarction
Slower titration: Increase by 12.5-25 mcg every 6-8 weeks (not 4-6 weeks)
Less aggressive TSH targets:
- Target TSH 4-6 mIU/L may be acceptable in very elderly (>80 years) or frail patients
- Avoid TSH <0.5 mIU/L due to increased fracture and atrial fibrillation risk
Screen more carefully:
Consider subclinical hypothyroidism differently:
- TSH 4.5-10 mIU/L with normal free T4 may not require treatment in elderly
- Weigh risks of treatment (atrial fibrillation, bone loss) against uncertain benefits
- Some evidence suggests mild TSH elevation may be physiologic in aging
Medication Interactions in Elderly
Older adults commonly take medications affecting levothyroxine:
- Proton pump inhibitors: Reduce absorption
- Calcium and iron supplements: Separate by 4 hours
- Amiodarone: Can cause both hypo- and hyperthyroidism; check TSH every 6 months 3
Cognitive and Functional Assessment
In elderly patients with fatigue:
- Depression is common and often coexists with or mimics hypothyroidism 4
- Polypharmacy may contribute to fatigue
- Sleep apnea increases with age and hypothyroidism 1
- Functional decline may be multifactorial; thyroid replacement alone may not resolve fatigue
Clinical Reasoning Summary
The evaluation pathway prioritizes TSH as the single best screening test because it is highly sensitive for primary hypothyroidism (the vast majority of cases). Free T4 is added only when TSH is abnormal to distinguish overt from subclinical disease and to identify rare central hypothyroidism 1.
Treatment decisions follow a clear TSH threshold: >10 mIU/L warrants treatment; 4.5-10 mIU/L requires clinical judgment based on symptoms, antibodies, and patient factors 1. This approach balances the risks of under-treatment (persistent symptoms, cardiovascular effects) against over-treatment (atrial fibrillation, osteoporosis).
Age-based dosing modifications reflect the higher cardiovascular risk in elderly patients, where rapid thyroid hormone replacement can unmask coronary disease 1. The conservative approach in older adults also acknowledges that mild TSH elevation may represent physiologic aging rather than pathology requiring intervention.
The most common pitfall is over-testing and over-diagnosing hypothyroidism in fatigued patients 5, 3. Most fatigue is not thyroid-related, and normal TSH definitively excludes hypothyroidism. Clinicians should resist pressure to treat "subclinical" disease with normal TSH values, as no evidence supports benefit 3.